Abstract: Disclosed herein are thermosensitive hydrogels including at least one thermosensitive polymer and at least one polypeptide. The hydrogels may further include one or more therapeutic and/diagnostic agents and can be used to selectively and controllably deliver such agents to specified tissues and organ systems.

Abstract: A solid electrolyte including an inorganic lithium ion conductive film and a porous layer on a surface of the inorganic lithium ion conductive film, wherein the porous layer includes a first porous layer and a second porous layer, and the second porous layer is disposed between the inorganic lithium ion conductive film and the first porous layer, and wherein the first porous layer has a size greater which is than a pore size of the second porous layer.

Abstract: Various examples are directed to apparatus and methods for providing a door latch block assembly. An apparatus includes a first planar surface configured to mount parallel to and facing away from a first side of a door frame, and a second planar surface configured to mount flush with and facing toward the first side of the door frame. The apparatus further includes a rectangular protrusion extending from the second planar surface configured to extend through an aperture in the door frame and protrude from a second side of the door frame. The apparatus also includes cylindrical openings extending through the latch block apparatus configured to receive hardware for affixing a latching mechanism to a distal end of the protrusion. The apparatus is configured to provide precise alignment of the latching mechanism for securing the door frame to a door.

Abstract: A high-linearity linearizer system includes a multi-stage linearizer circuit formed by cascading multiple linearizer circuits. The multi-stage linearizer circuit is configured to pre-distort an input signal to generate a pre-distorted signal. A non-linear high-power amplifier (HPA) having non-linear characteristics is coupled to the multi-stage linearizer circuit and is configured to amplify the pre-distorted signal. Pre-distortion characteristics of the multi-stage linearizer circuit are configured to counter the non-linear characteristics of the non-linear HPA and to compensate a non-linearity of the non-linear HPA to achieve a desired level of linearity.

Abstract: An adaptive linearizer system includes an adaptive linearizer circuit that is configured to pre-distort an input signal based on one or more control signals to generate a pre-distorted signal, and a non-linear high-power amplifier (HPA) having non-linear characteristics that is coupled to the adaptive linearizer circuit. The nonlinear HPA amplifies the pre-distorted signal. The pre-distortion characteristics of the adaptive linearizer circuit provide for countering the non-linear characteristics of the non-linear HPA and compensating a non-linearity of the non-linear HPA.

Abstract: An access door for insertion into an opening in a construction surface is provided. The access door has a frame for engagement with edges of the opening in the construction surface. The frame has a channel formed therein for receiving a thermally insulative material to provide a thermal break between the frame and the construction surface. A door is operatively coupled to the frame and movable between an open position allowing access through the opening in the construction surface and a closed position preventing access through the opening in the construction surface.

Abstract: An access door for insertion into an opening in a construction surface is provided. The access door has a frame for engagement with edges of the opening in the construction surface. The frame has a channel formed therein for receiving a thermally insulative material to provide a thermal break between the frame and the construction surface. A door is operatively coupled to the frame and movable between an open position allowing access through the opening in the construction surface and a closed position preventing access through the opening in the construction surface.

Abstract: An adaptive linearizer system includes an adaptive linearizer circuit that is configured to pre-distort an input signal based on one or more control signals to generate a pre-distorted signal, and a non-linear high-power amplifier (HPA) having non-linear characteristics that is coupled to the adaptive linearizer circuit. The nonlinear HPA amplifies the pre-distorted signal. The pre-distortion characteristics of the adaptive linearizer circuit provide for countering the non-linear characteristics of the non-linear HPA and compensating a non-linearity of the non-linear HPA.

Abstract: A high-linearity linearizer system includes a multi-stage linearizer circuit formed by cascading multiple linearizer circuits. The multi-stage linearizer circuit is configured to pre-distort an input signal to generate a pre-distorted signal. A non-linear high-power amplifier (HPA) having non-linear characteristics is coupled to the multi-stage linearizer circuit and is configured to amplify the pre-distorted signal. Pre-distortion characteristics of the multi-stage linearizer circuit are configured to counter the non-linear characteristics of the non-linear HPA and to compensate a non-linearity of the non-linear HPA to achieve a desired level of linearity.

Abstract: A clip-in access door for covering an opening in a construction surface has a frame for mounting in the opening, a door mounted on the frame, and a plurality of clips mounted on the frame for securing the frame in the opening of the construction surface. The clips along at least one edge of the frame are rotatable between an insert position and a lock position. Methods of using the clip-in access door are provided.

Abstract: This invention relates to a combination product comprising a compound of formula I wherein X, R1, R2, R3, R4, R5, R6, R7 and R9 are as described herein, and one or more further biologically active compounds as described herein, particularly anti-parasitic agents.

Abstract: This invention relates to a combination product comprising a compound of formula I wherein X, R1, R2, R3, R4, R5, R6, R7 and R9 are as described herein, and one or more further biologically active compounds as described herein, particularly anti-parasitic agents.

Abstract: This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.

Abstract: This invention relates to a combination product comprising a compound of formula I wherein X, R1, R2, R3, R4, R5, R6, R7 and R9 are as described herein, and one or more further biologically active compounds as described herein, particularly anti-parasitic agents.

Abstract: This invention relates to a combination product comprising a range of 1-aryl-4 -cyclopropylpyrazoles in which there is at least one fluorine attached to the cyclopropyl ring, and one o more further therapeutic agents, particularly anti-parasitic agents.

Abstract: This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.

Abstract: This invention relates to a combination product comprising a range of 1-aryl-4-cyclopropylpyrazoles in which there is at least one fluorine attached to the cyclopropyl ring, and one o more further therapeutic agents, particularly anti-parasitic agents.

Abstract: This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.

Abstract: This invention relates to a combination product comprising a compound of formula I wherein X, R1, R2, R3, R4, R5, R6, R7 and R9 are as described herein, and one or more further biologically active compounds as described herein, particularly anti-parasitic agents.

Abstract: This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.